Abstract SAT0167 Table 1

Adverse Events (% patients)	ALN (N = 167)	PBO (N = 168)	Upper GI Adverse Events (% patients)	ALN (N = 167)	PBO (N = 168)

Any	81.4	84.5	Any upper GI	10.8	11.9
Drug-related ^[1]	9.0	11.9	Drug-related ^[1]	4.2	6.5
Discontinued	2.4	3.0	Abdominal pain	4.8	4.8
Serious ^[2]	5.4	4.8	Dyspepsia	2.4	4.8

↵[1] Drug-related indicates that the investigator considered the event possibly related to study drug while still blinded to treatment allocation.
↵[2] Serious adverse events include those requiring hospitalisation or causing death.